Collectively, these results suggest that NCD might exert its immunomodulatory and anti-tumor effects by targeting JAK2 and inhibiting the JAK2-STAT3 signaling pathway, thereby promoting the expression of immune-activating genes in TNBC cells. This evidence concerns the gene JAK2 and neoplasm.